MOTIVATION - PowerPoint PPT Presentation

1 / 45
About This Presentation
Title:

MOTIVATION

Description:

MOTIVATION Our deepest fear is not that we are inadequate, our deepest fear is that we are powerful beyond measure -Marianne Williamson – PowerPoint PPT presentation

Number of Views:55
Avg rating:3.0/5.0
Slides: 46
Provided by: BUN118
Category:

less

Transcript and Presenter's Notes

Title: MOTIVATION


1
MOTIVATION
  • Our deepest fear is not that we are inadequate,
    our deepest fear is that we are powerful beyond
    measure
  • -Marianne Williamson

2
DERMATOLOGY
  • NOT DONE YET!

3
OTITIS EXTERNA
  • An acute or chronic inflammatory disease of the
    external ear canal
  • Clinical signs
  • Head rubbing or shaking
  • Ear scratching
  • Head tilt with the affected ear tilted down
  • Malodorous otic discharge (brown,
    greenish-yellow)
  • Lichenification, hyperpigmentation, crusts,
    erythema and excoriations may be present
  • Aural hematoma

4
OTITIS EXTERNA
NOTE THE EXCESS BROWN EXUDATE
ERYTHEMA, HYPERPIGMENTATION, LICHENIFICATION
AURAL HEMATOMA
5
OTITIS EXTERNA
  • PREDISPOSING FACTORS
  • Conformation
  • Heavy, pendulous ears
  • Stenotic ear canals
  • Ear hair
  • Excessive moisture
  • Frequent bathing or swimming
  • Hypersensitivities
  • Food allergy, atopy

6
OTITIS EXTERNA
  • DIAGNOSIS
  • Otoscopic exam
  • Clinical signs
  • Cytology, ear smear
  • Yeast, bacteria, cerumen, skin cells

7
OTITIS EXTERNA
  • MALASSEZZIA OTITIS

Malassezzia resemble footprints, bowling pins,
or snowmen
8
OTITIS EXTERNA
  • BACTERIAL OTITIS

ROD-SHAPED BACTERIA AND A SKIN CELL
9
OTITIS EXTERNA
  • TREATMENT
  • Always treat the underlying condition if present
  • Topical meds instilled daily
  • Antibacterial, antifungal, or combination
    products often with steroids (otomax, tresaderm,
    baytril otic)
  • Cleaning ears during treatment
  • Surgical intervention may be required
  • Aural hematoma
  • Chronic conditions (Total Ear Canal Ablation)

10
ANAL SAC DISEASE
  • The anal sacs are located between the muscle
    layers of the anus at the 4 and 8 oclock
    positions. Each sac connects to the surface
    through a narrow duct.
  • Sebaceous glands produce a foul-smelling oily,
    brown fluid. The sacs are naturally expressed
    during defecation, but can sometimes overfill.

11
ANAL SAC DISEASE
12
ANAL SAC DISEASE
  • IMPACTION
  • When the sacs overfill, the water can be
    reabsorbed, and the material dries out.
  • Sacs become a source of discomfort for the dog
    and are difficult to express at this time.
  • Impaction can lead to abscessation and rupture.
  • Clinical signs include scooting rear end across
    the floor, painful defecation, tail chasing,
    perianal erythema, and/or swelling

13
ANAL SAC DISEASE
14
ANAL SAC DISEASE
  • DIAGNOSIS
  • Palpation (rectally or externally)
  • Clinical signs
  • TREATMENT
  • Express contents
  • Flush sac
  • Instill antibiotic ointment
  • Oral antibiotics, anti-inflammatories
  • Surgery?

15
ANAL SAC DISEASE
WEARING GLOVES, GENTLY MILK THE GLANDS IN AN
UPWARD MOTION TO EXPRESS.
16
TUMORS OF THE SKIN
  • Tumors are a new growth of tissue characterized
    by progressive, uncontrolled proliferation of
    cells.
  • Benign vs. Malignant
  • Localized vs. Invasive
  • Adenoma/Carcinoma vs. Sarcomas

17
BENIGN TUMORS OF THE SKIN
  • HISTIOCYTOMA small, button-like tumors that are
    usually pink, hairless, and raised. They are
    rapidly growing

Common locations include the pinnae, head, and
legs
18
BENIGN TUMORS OF THE SKIN
  • HISTIOCYTOMA
  • Occurs almost exclusively in young dogs lt4yrs old
  • DIAGNOSIS
  • Appearance
  • biopsy
  • TREATMENT
  • These tumors may spontaneously regress, but
    surgical excision is the treatment of choice

ROUND CELL TUMOR
19
BENIGN TUMORS OF THE SKIN
  • LIPOMA tumor of the subcutaneous adipocytes (fat
    cells) that are typically freely movable and
    well-circumscribed
  • Common in older, female, obese dogs
  • DIAGNOSIS
  • Biopsy
  • Fine needle aspirate

20
BENIGN TUMORS OF THE SKIN
  • LIPOMA
  • TREATMENT
  • Surgical excision
  • Benign neglect

lipocytes
21
BENIGN TUMORS OF THE SKIN
  • PAPILLOMAS wart-like growths that develop as
    smooth, white/pink/pigmented, elevated lesions in
    the oral cavity (oral papillomatosis) or on the
    skin (cutaneous papillomas)
  • These growths are caused by a papillomavirus

22
BENIGN TUMORS OF THE SKIN
  • PAPILLOMAS
  • DIAGNOSIS
  • Appearance
  • Biopsy
  • TREATMENT
  • Usually spontaneous regression
  • Autogenous vaccine

23
BENIGN TUMORS OF THE SKIN
  • SEBACEOUS GLAND CYSTS Slow growing,
    encapuslated, round, and exude a gray, cheeselike
    material. Caused by degenerative changes in the
    glandular area surrounding the follicle.
  • Common in cocker spaniels
  • DIAGNOSIS
  • Contents of the cyst
  • histology
  • TREATMENT
  • Surgical removal of entire encapsulated cyst

24
BENIGN TUMORS OF THE SKIN
SEBACEOUS CYSTS
25
MALIGNANT SKIN TUMORS
  • FELINE VACCINE-INDUCED FIBROSARCOMAS rapidly
    developing, highly invasive, malignant tumors
    that occur at the site of vaccination 4-6 weeks
    later.
  • VACCINES MOST COMMONLY IMPLICATED ARE THOSE WITH
    ADJUVANTS (substance that enhances the immune
    response by increasing the stability of a vaccine
    in the body) SUCH AS FeLV AND RABIES

26
MALIGNANT SKIN TUMORS
  • VACCINE-ASSOCIATED SARCOMAS
  • DIAGNOSIS
  • Biopsy of fine needle aspirate
  • Physical exam findings
  • Swelling in area of recent vaccination
  • Rapidly growing firm elongated mass

27
MALIGNANT SKIN TUMORS
  • VACCINE-ASSOCIATED SARCOMAS
  • TREATMENT
  • Radical surgical excision which may involve limb
    amputation is the treatment of choice
  • CLIENT INFORMATION
  • Poor prognosis if not detected early and treated
    aggressively
  • Inflammatory lumps may do develop after vaccines
    but usually disappear within 1-2 weeks

28
MALIGNANT SKIN TUMORS
FELINE VACCINE-ASSOCIATED SARCOMAS
29
MALIGNANT SKIN TUMORS
  • MAST CELL TUMORS firm nodules on the skin that
    may be ulcerated or edematous. Mast cells contain
    histamine and heparin

30
MALIGNANT SKIN TUMORS
FINE NEEDLE ASPIRATE OF MAST CELL TUMOR NOTE THE
NUMEROUS GRANULES
31
MALIGNANT SKIN TUMORS
IN CATS, MAST CELL TUMORS ARE USUALLY BENIGN AND
MAY SPONTANEOUSLY REGRESS
32
MALIGNANT SKIN TUMORS
  • MAST CELL TUMOR
  • TREATMENT
  • Chemotherapy
  • Radiation therapy
  • BENADRYL
  • H2 blockers to treat gastric ulceration and
    irritation
  • PROGNOSIS
  • Depends on biopsy grading results

33
MALIGNANT SKIN TUMORS
  • MELANOMA (Benign or Malignant)
  • BENIGN small, slow growing, hairless, pigmented
  • MALIGNANT large, dome-shaped sessile /-
    pigmentation
  • Ex Tumors of the oral cavity and digits
  • Poor prognosis
  • Metastasize readily
  • Recurrence after surgery is common

34
MALIGNANT SKIN TUMORS
TREATMENT INVOLVES SURGICAL REMOVAL AND POSSIBLY
TREATMENT WITH THE VACCINE
35
Immune mediated conditions
  • Pemphigus (blistering disease)Foliaceus
  • Pemphigus Erythematosus
  • Pemphigus Vulgaris
  • Bullous Pemphigoid
  • Lupus Erythematosus
  • Alopecia Areata
  • Pseudopelade

36
Immune mediated
  • antibody-mediated or cell-mediated immune
    response directed against normal components of
    the skin
  • Pemphigus complex pemphigus foliaceus (PF),
    pemphigus erythematosus (PE), panepidermal
    pustular pemphigus, pemphigus vulgaris (PV), and
    paraneoplastic pemphigus
  • autoantibodies target adhesion proteins, intra-
    or subepidermal separation results in autoimmune
    blistering skin disease

37
Pemphigus Foliaceus
  • target the desmosomes between keratinocytes
  • IgG autoantibodies
  • Genetics Akitas and chows
  • age of onset is variable
  • 1 to 16 years in dogs
  • less than 1 year of age to up to 17 years of age
    in cats
  • UV light

A pustule just caudal to the planum nasale of a
dog alopecia and erythema are also present in
the dorsal nasal region
38
Pemphigus Foliaceus
  • Drugs cimetidine, cephalexin, amoxicillin and
    clavulanic acid, ampicillin, and
    trimethoprim-sulfonamide combinations
  • Lesions
  • erythematous macules that then progress rapidly
    to a pustular stage
  • crusting dermatitis, Scale, alopecia, erosions,
    collarettes, and erythema
  • "face, feet and ears"

39
Pemphigus Foliaceus
Ulceration from a deep pyoderma in a patient
with pemphigus foliaceus. Ulcers should not be
seen in pemphigus foliaceus patients unless
another condition such as a pyoderma is present.
Note the symmetrical appearance of the facial
lesions.
Crusts from ruptured pustules on a dog's nasal
planum and dorsal nasal region.
40
Pemphigus Foliaceus
  • Clinical signs
  • Skin lesions
  • Systemic signs such as fever, lethargy, anorexia,
    and lymphadenopathy
  • /- Pruritus (skin lesions develop before
    pruritus)

41
Pemphigus Foliaceus
  • mild and localized disease
  • erosions and yellowish crusts
  • Dx
  • acantholytic keratinocytes (arrows), histology,
    IFA
  • Dogs can have a mild to moderate leukocytosis
    with neutrophilia and a mild to moderate
    nonregenerative, normocytic, and normochromic
    anemia (anemia of chronic disease
  • Cats as above and basophilia, eosinophilia,
    lymphopenia, and monocytosis

42
Pemphigus Foliaceus
43
Pemphigus Foliaceus
  • Treatments
  • Glucocorticoids
  • Prednisone is initially started at 2 mg/kg/day
    orally in dogs,
  • prednisolone is initially started at 2 to 4
    mg/kg/day orally in cats
  • cats, triamcinolone can be initially dosed at 2
    to 4 mg/kg/day orally, and dexamethasone can be
    initially dosed at 0.3 to 0.6 mg/kg/day orally

44
Pemphigus Foliaceus
  • Prognosis
  • Mortality from pemphigus foliaceus can occur
    because of disease progression, medication side
    effects, or client-requested euthanasia.
  • Severe cases of pemphigus foliaceus can result in
    marked cachexia or sepsis secondary to
    infections.
  • Adverse effects are common with most of the
    medications used for pemphigus foliaceus.
  • Euthanasia accounted for almost 70 of deaths in
    pemphigus foliaceus dogs in one retrospective
    study
  • Client education

45
References
  • Common diseases of companion animals, Alleice
    Summers, 2007
  • Immune-Mediated Feline Skin Diseases (V69),
    Western Veterinary Conference 2010, Lauren R.
    Pinchbeck
  • http//veterinarymedicine.dvm360.com/vetmed/Articl
    eStandard/Article/detail/653149
Write a Comment
User Comments (0)
About PowerShow.com